Preliminary results with administration of recombinant human erythropoietin in sickle cell/beta-thalassemia patients during pregnancy. (atsiveria naujas langas)

Bourantas K, Makrydimas G, Georgiou J, Tsiara S, Lolis D.

Šaltinis‎: Eur J Haematol 1996;56(5):326-8.

Kodas‎: PubMed 8641410

https://www.ncbi.nlm.nih.gov/pubmed/8641410 (atsiveria naujas langas)

On the use of hydroxyurea/erythropoietin combination therapy for sickle cell disease. (atsiveria naujas langas)

el-Hazmi MA, al-Momen A, Kandaswamy S, Huraib S, Harakati M, al-Mohareb F, Warsy AS.

Šaltinis‎: Acta Haematol 1995;94(3):128-34.

Kodas‎: PubMed 7502628

https://www.ncbi.nlm.nih.gov/pubmed/7502628 (atsiveria naujas langas)

Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review. (atsiveria naujas langas)

Little JA, McGowan VR, Kato GJ, Partovi KS, Feld JJ, Maric I, Martyr S, Taylor JG 6th, Machado RF, Heller T, Castro O, Gladwin MT.

Šaltinis‎: Haematologica 2006;91(8):1076-83.

Kodas‎: PubMed 16885048

https://www.ncbi.nlm.nih.gov/pubmed/16885048 (atsiveria naujas langas)

Use of erythropoietin in a pregnant Jehovah's Witness with sickle-cell disease. (atsiveria naujas langas)

Tan TL, Ahmad H, Jhavar R, Patel R, Harrison C, Oteng-Ntim E.

Šaltinis‎: J Obstet Gynaecol 2007;27(1):82-3.

Kodas‎: PubMed 17365469

DOI‎: 10.1080/01443610601062739

https://www.ncbi.nlm.nih.gov/pubmed/17365469 (atsiveria naujas langas)

The use of barbiturate coma as salvage therapy in a postoperative Jehovah's Witness patient with life-threatening anemia. (atsiveria naujas langas)

Wang SW, Badami CD, Deitch EA.

Šaltinis‎: Am Surg 2009;75(12):1175-8.

Kodas‎: PubMed 19999907

https://www.ncbi.nlm.nih.gov/pubmed/19999907 (atsiveria naujas langas)